precision for medicine (uk labs) limitedEstimated Valuation
£2.6m
Pomanda estimates the enterprise value of PRECISION FOR MEDICINE (UK LABS) LIMITED at £2.6m based on a Turnover of £2.9m and 0.88x industry multiple (adjusted for size and gross margin).
precision for medicine (uk labs) limitedEstimated Valuation
£1.4m
Pomanda estimates the enterprise value of PRECISION FOR MEDICINE (UK LABS) LIMITED at £1.4m based on an EBITDA of £348k and a 4.09x industry multiple (adjusted for size and gross margin).
precision for medicine (uk labs) limitedEstimated Valuation
£41.9k
Pomanda estimates the enterprise value of PRECISION FOR MEDICINE (UK LABS) LIMITED at £41.9k based on Net Assets of £24k and 1.75x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Precision For Medicine (uk Labs) LimitedOverview
Precision For Medicine (uk Labs) Limited is a live company located in hertfordshire, SG8 5HD with a Companies House number of 08092729. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in June 2012, it's largest shareholder is
pmg international holdings inc.
with a 100% stake. Precision For Medicine (uk Labs) Limited is a established,
small sized company, Pomanda has estimated its turnover at
£2.9m with
high
growth in recent years.
Precision For Medicine (uk Labs) Limited Health Check
Pomanda's financial health check has awarded Precision For Medicine (Uk Labs) Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
2 Strong
3 Regular
6 Weak
Size
annual sales of £2.9m, make it smaller than the average company (£4.3m)
£2.9m - Precision For Medicine (uk Labs) Limited
£4.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 24%, show it is growing at a faster rate (6.7%)
24% - Precision For Medicine (uk Labs) Limited
6.7% - Industry AVG
Production
with a gross margin of 25.9%, this company has a higher cost of product (46.9%)
25.9% - Precision For Medicine (uk Labs) Limited
46.9% - Industry AVG
Profitability
an operating margin of 5% make it more profitable than the average company (3.6%)
5% - Precision For Medicine (uk Labs) Limited
3.6% - Industry AVG
Employees
with 25 employees, this is below the industry average (44)
25 - Precision For Medicine (uk Labs) Limited
44 - Industry AVG
Pay Structure
on an average salary of £64.5k, the company has an equivalent pay structure (£64.5k)
£64.5k - Precision For Medicine (uk Labs) Limited
£64.5k - Industry AVG
Efficiency
resulting in sales per employee of £117.2k, this is equally as efficient (£121.7k)
£117.2k - Precision For Medicine (uk Labs) Limited
£121.7k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is near the average (55 days)
50 days - Precision For Medicine (uk Labs) Limited
55 days - Industry AVG
Creditor Days
its suppliers are paid after 27 days, this is quicker than average (44 days)
27 days - Precision For Medicine (uk Labs) Limited
44 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Precision For Medicine (uk Labs) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 16 weeks, this is less cash available to meet short term requirements (32 weeks)
16 weeks - Precision For Medicine (uk Labs) Limited
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 99.2%, this is a higher level of debt than the average (44.4%)
99.2% - Precision For Medicine (uk Labs) Limited
44.4% - Industry AVG
PRECISION FOR MEDICINE (UK LABS) LIMITED financials
EXPORT
Precision For Medicine (Uk Labs) Limited's latest turnover from December 2023 is £2.9 million and the company has net assets of £24 thousand. According to their latest financial statements, Precision For Medicine (Uk Labs) Limited has 25 employees and maintains cash reserves of £910 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Turnover
2,931,000
2,275,000
1,912,000
1,536,000
2,152,000
2,495,000
2,791,000
2,790,000
3,436,000
3,184,000
3,051,000
1,321,000
Other Income Or Grants
Cost Of Sales
2,171,000
1,328,000
1,084,000
934,000
1,314,000
1,169,000
1,486,000
1,414,000
2,020,000
1,489,000
1,311,000
573,000
Gross Profit
760,000
947,000
828,000
602,000
838,000
1,326,000
1,305,000
1,376,000
1,416,000
1,695,000
1,740,000
748,000
Admin Expenses
615,000
833,000
1,169,000
1,002,000
1,191,000
1,867,000
2,015,000
2,419,000
1,812,000
1,799,000
1,756,000
677,000
Operating Profit
145,000
114,000
-341,000
-400,000
-353,000
-541,000
-710,000
-1,043,000
-396,000
-104,000
-16,000
71,000
Interest Payable
78,000
124,000
118,000
114,000
114,000
43,000
Interest Receivable
Pre-Tax Profit
145,000
114,000
-341,000
-400,000
-353,000
-541,000
-788,000
-1,167,000
-514,000
-208,000
-154,000
26,000
Tax
166,000
103,000
86,000
7,000
-2,000
112,000
147,000
42,000
12,000
-10,000
Profit After Tax
311,000
217,000
-255,000
-393,000
-355,000
-429,000
-641,000
-1,167,000
-514,000
-166,000
-142,000
16,000
Dividends Paid
Retained Profit
311,000
217,000
-255,000
-393,000
-355,000
-429,000
-641,000
-1,167,000
-514,000
-166,000
-142,000
16,000
Employee Costs
1,612,277
1,407,627
1,045,102
1,007,582
1,391,633
1,368,317
1,713,883
1,628,449
1,613,409
1,595,322
1,566,840
708,371
Number Of Employees
25
22
17
17
24
24
31
31
31
32
33
15
EBITDA*
348,000
271,000
-208,000
-324,000
-267,000
-102,000
-312,000
-622,000
11,000
289,000
448,000
200,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Tangible Assets
583,000
520,000
494,000
279,000
301,000
387,000
364,000
168,000
223,000
252,000
252,000
104,000
Intangible Assets
460,000
750,000
1,049,000
1,347,000
1,621,000
1,914,000
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
583,000
520,000
494,000
279,000
301,000
387,000
824,000
918,000
1,272,000
1,599,000
1,873,000
2,018,000
Stock & work in progress
97,000
Trade Debtors
407,000
331,000
290,000
385,000
340,000
798,000
1,134,000
329,000
616,000
608,000
418,000
485,000
Group Debtors
570,000
882,000
51,000
369,000
36,000
151,000
245,000
241,000
414,000
Misc Debtors
461,000
298,000
466,000
176,000
822,000
538,000
513,000
361,000
175,000
93,000
388,000
Cash
910,000
350,000
128,000
307,000
94,000
140,000
82,000
122,000
769,000
143,000
176,000
338,000
misc current assets
total current assets
2,348,000
1,861,000
935,000
868,000
1,625,000
1,512,000
1,216,000
1,212,000
1,991,000
1,167,000
1,101,000
1,211,000
total assets
2,931,000
2,381,000
1,429,000
1,147,000
1,926,000
1,899,000
2,040,000
2,130,000
3,263,000
2,766,000
2,974,000
3,229,000
Bank overdraft
Bank loan
Trade Creditors
161,000
30,000
63,000
61,000
146,000
96,000
132,000
103,000
92,000
77,000
113,000
112,000
Group/Directors Accounts
2,528,000
2,450,000
1,629,000
1,073,000
1,092,000
545,000
536,000
3,126,000
528,000
142,000
198,000
115,000
other short term finances
hp & lease commitments
18,000
13,000
61,000
82,000
59,000
other current liabilities
218,000
188,000
241,000
262,000
544,000
759,000
426,000
509,000
1,493,000
770,000
724,000
959,000
total current liabilities
2,907,000
2,668,000
1,933,000
1,396,000
1,782,000
1,400,000
1,112,000
3,751,000
2,174,000
1,071,000
1,094,000
1,186,000
loans
1,528,000
1,528,000
1,528,000
1,528,000
hp & lease commitments
15,000
76,000
95,000
Accruals and Deferred Income
other liabilities
provisions
116,000
total long term liabilities
1,543,000
1,604,000
1,623,000
1,644,000
total liabilities
2,907,000
2,668,000
1,933,000
1,396,000
1,782,000
1,400,000
1,112,000
3,751,000
3,717,000
2,675,000
2,717,000
2,830,000
net assets
24,000
-287,000
-504,000
-249,000
144,000
499,000
928,000
-1,621,000
-454,000
91,000
257,000
399,000
total shareholders funds
24,000
-287,000
-504,000
-249,000
144,000
499,000
928,000
-1,621,000
-454,000
91,000
257,000
399,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Operating Activities
Operating Profit
145,000
114,000
-341,000
-400,000
-353,000
-541,000
-710,000
-1,043,000
-396,000
-104,000
-16,000
71,000
Depreciation
203,000
157,000
133,000
76,000
86,000
125,000
108,000
123,000
133,000
100,000
53,000
11,000
Amortisation
314,000
290,000
298,000
274,000
293,000
411,000
118,000
Tax
166,000
103,000
86,000
7,000
-2,000
112,000
147,000
42,000
12,000
-10,000
Stock
-97,000
97,000
Debtors
-73,000
704,000
246,000
-970,000
159,000
238,000
141,000
-229,000
198,000
99,000
52,000
873,000
Creditors
131,000
-33,000
2,000
-85,000
50,000
-36,000
29,000
11,000
15,000
-36,000
1,000
112,000
Accruals and Deferred Income
30,000
-53,000
-21,000
-282,000
-215,000
333,000
-83,000
-984,000
723,000
46,000
-235,000
959,000
Deferred Taxes & Provisions
-116,000
116,000
Cash flow from operations
748,000
-416,000
-387,000
286,000
-593,000
69,000
-263,000
-1,463,000
551,000
242,000
58,000
504,000
Investing Activities
capital expenditure
-266,000
-183,000
-348,000
-54,000
-2,000
-304,000
-67,000
-80,000
-119,000
-319,000
-2,147,000
Change in Investments
cash flow from investments
-266,000
-183,000
-348,000
-54,000
-2,000
-304,000
-67,000
-80,000
-119,000
-319,000
-2,147,000
Financing Activities
Bank loans
Group/Directors Accounts
78,000
821,000
556,000
-19,000
547,000
9,000
-2,590,000
2,598,000
386,000
-56,000
83,000
115,000
Other Short Term Loans
Long term loans
-1,528,000
1,528,000
Hire Purchase and Lease Commitments
-18,000
5,000
-63,000
-82,000
4,000
154,000
other long term liabilities
share issue
3,190,000
-31,000
383,000
interest
-78,000
-124,000
-118,000
-114,000
-114,000
-43,000
cash flow from financing
78,000
821,000
556,000
-19,000
547,000
-9,000
527,000
883,000
155,000
-166,000
123,000
1,983,000
cash and cash equivalents
cash
560,000
222,000
-179,000
213,000
-46,000
58,000
-40,000
-647,000
626,000
-33,000
-162,000
338,000
overdraft
change in cash
560,000
222,000
-179,000
213,000
-46,000
58,000
-40,000
-647,000
626,000
-33,000
-162,000
338,000
precision for medicine (uk labs) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for precision for medicine (uk labs) limited. Get real-time insights into precision for medicine (uk labs) limited's credit score, group structure and payment trends.
Precision For Medicine (uk Labs) Limited Competitor Analysis
Perform a competitor analysis for precision for medicine (uk labs) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in SG8 area or any other competitors across 12 key performance metrics.
precision for medicine (uk labs) limited Ownership
PRECISION FOR MEDICINE (UK LABS) LIMITED group structure
Precision For Medicine (Uk Labs) Limited has no subsidiary companies.
Ultimate parent company
PRECISION MEDICINE GROUP HOLDINGS INC
#0017290
PMG INTERNATIONAL HOLDINGS INC
#0102715
2 parents
PRECISION FOR MEDICINE (UK LABS) LIMITED
08092729
PRECISION FOR MEDICINE (UK LABS) LIMITED Shareholders
The sole shareholder of Precision For Medicine (Uk Labs) Limited is Pmg International Holdings Inc..
pmg international holdings inc.
100%
precision for medicine (uk labs) limited directors
Precision For Medicine (Uk Labs) Limited currently has 4 directors.
The longest serving directors include
Mr John Mariano, Jr. (May 2020) and
Mr Krzysztof Mazurek (Nov 2021).
precision for medicine (uk labs) limited company details
company number
08092729
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
June 2012
age
13
incorporated
UK
ultimate parent company
PRECISION MEDICINE GROUP HOLDINGS INC
accounts
Small Company
last accounts submitted
December 2023
previous names
asterand uk acquisition limited (May 2020)
accountant
-
auditor
GRANT THORNTON UK LLP
address
2a orchard road, royston, hertfordshire, SG8 5HD
Bank
CITIBANK UK
Legal Advisor
-
precision for medicine (uk labs) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to precision for medicine (uk labs) limited. Currently there are 1 open charges and 2 have been satisfied in the past.
precision for medicine (uk labs) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PRECISION FOR MEDICINE (UK LABS) LIMITED. This can take several minutes, an email will notify you when this has completed.
precision for medicine (uk labs) limitedCompanies House Filings - See Documents
